Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial
Titel:
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial
Auteur:
Mateos, Maria-Victoria Cavo, Michele Blade, Joan Dimopoulos, Meletios A Suzuki, Kenshi Jakubowiak, Andrzej Knop, Stefan Doyen, Chantal Lucio, Paulo Nagy, Zsolt Pour, Ludek Cook, Mark Grosicki, Sebastian Crepaldi, Andre Liberati, Anna Marina Campbell, Philip Shelekhova, Tatiana Yoon, Sung-Soo Iosava, Genadi Fujisaki, Tomoaki Garg, Mamta Krevvata, Maria Chen, Ying Wang, Jianping Kudva, Anupa Ukropec, Jon Wroblewski, Susan Qi, Ming Kobos, Rachel San-Miguel, Jesus